P.327 Efficacy and safety of AXS-05, an oral, NMDA receptor antagonist with multimodal activity in major depressive disorder

Authors
Category Primary study
JournalEuropean Neuropsychopharmacology
Year 2020
This article has no abstract
Epistemonikos ID: 87691344a3dcbd0d5c645ec4c68ac7194091a13e
First added on: Feb 12, 2025